FDA Clears Overdose Antidote Amid Zohydro Uproar
Facing heavy criticism over approval of narcotic painkiller Zohydro, the U.S. Food and Drug Administration on Thursday launched a public-relations counteroffensive, announcing approval of an antidote for opioid overdoses and staging...To view the full article, register now.
Already a subscriber? Click here to view full article